News related to Elspar (Asparaginase) and/or conditions it is approved for
Volasertib Phase II data published including new overall survival results in older patients with acute myeloid leukemia
Source: Clinical Trials / Drug Trials News From Medical News Today [2014.07.10]
Results from a Phase II study that compared volasertib plus low-dose cytarabine (LDAC), a form of chemotherapy, versus LDAC alone in older patients with untreated acute myeloid leukemia (AML) were...
The leukemia battle aided by lipids
Source: Lymphoma / Leukemia / Myeloma News From Medical News Today [2014.06.18]
T cells use a novel mechanism to fight leukemia. They may recognize unique lipids produced by cancer cells and kill tumor cells expressing these lipid molecules.
Many Childhood Leukemia Survivors Aren't Taking 'Maintenance' Meds: Study
Source: MedicineNet Leukemia Specialty [2014.06.09]
Title: Many Childhood Leukemia Survivors Aren't Taking 'Maintenance' Meds: Study
Category: Health News
Created: 6/6/2014 12:35:00 PM
Last Editorial Review: 6/9/2014 12:00:00 AM
Nonadherence to leukemia maintenance medication in childhood triples relapse risk
Source: Compliance News From Medical News Today [2014.06.04]
An estimated 25 percent of children in remission from acute lymphocytic leukemia (ALL) are missing too many doses of an essential maintenance medication that minimizes their risk of relapse...
Source: MedicineNet Bladder Cancer Specialty [2014.05.08]
Category: Diseases and Conditions
Created: 8/2/2013 2:36:00 PM
Last Editorial Review: 5/8/2014 12:00:00 AM
New Drug Combo Might Help Older, Sicker Patients With Leukemia
Source: MedicineNet rituximab Specialty [2014.01.10]
Title: New Drug Combo Might Help Older, Sicker Patients With Leukemia
Category: Health News
Created: 1/9/2014 2:35:00 PM
Last Editorial Review: 1/10/2014 12:00:00 AM
New benchmark study of unrelated bone marrow transplantation for leukemia
Source: The Doctors Lounge - Hematology
Researchers at the University of Minnesota led the largest study to date in patients with leukemia undergoing bone marrow transplantation from unrelated donors.
ABT-199: Novel Bcl-2 specific inhibitor updated results confirm substantial activity and durable responses in high-risk CLL
Source: Lymphoma / Leukemia / Myeloma News From Medical News Today [2014.06.16]
Chronic Lymphocytic Leukaemia (CLL) is the most common leukemia in adults in the Western world and is diagnosed in approximately 5 persons per 100,000 population per year.